Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation
- 1 November 1984
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 108 (5) , 1244-1249
- https://doi.org/10.1016/0002-8703(84)90748-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Ventricular arrhythmias: Use of electrophysiologic studiesAmerican Heart Journal, 1983
- Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refutedInternational Journal of Cardiology, 1983
- Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardiaAmerican Heart Journal, 1983
- Amiodarone in Refractory Life-Threatening Ventricular ArrhythmiasAnnals of Internal Medicine, 1983
- Failure of bretylium to suppress inducible ventricular tachycardiaAmerican Heart Journal, 1983
- Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrestThe American Journal of Cardiology, 1983
- Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: An orally effective analog of bretylium for suppression of ventricular tachyarrhythmiasThe American Journal of Cardiology, 1982
- Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orallyThe American Journal of Cardiology, 1982
- Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1980
- ANTAGONISM OF THE HYPOTENSIVE ACTION OF BETHANIDINE AND DEBRISOQUINE BY TRICYCLIC ANTIDEPRESSANTSThe Lancet, 1969